AI Drug Discovery News
Genesis partners with NVIDIA to boost AI for designing drugs
Longevity Technology - 13-Nov-2024
NVIDIA will support Genesis in optimizing neural networks for 3D data handling
Read more...AI-developed drug improves lung function in idiopathic pulmonary fibrosis
FierceBiotech - 12-Nov-2024
Drug improved chronic cough symptoms, contributing to a better quality of life\
Read more...Can machine learning discover lifespan-extending drugs for mice?
Live Forever Club - 09-Nov-2024
This highlights promising paths for potential anti-ageing therapies
Read more...Terray raised $120 million to advance AI-driven drug discovery
Longevity Technology - 21-Oct-2024
Their partnership with Calico focuses on age-related disease treatments
Read more...Shift Bioscience raised $16 million to further its AI-driven platform
Longevity Technology - 15-Oct-2024
Shift aims to treat diseases like heart issues and arthritis by addressing aging’s root causes
Read more...Insilico's AI-designed drug proves effective in treating lung disease
Longevity Technology - 20-Sep-2024
Phase 2a trial results show positive outcomes among pulmonary fibrosis patients
Read more...OpenAI backs AI startup Chai Discovery in drug discovery revolution
Longevity Technology - 17-Sep-2024
An AI model set to transform drug discovery through cutting-edge molecular predictions
Read more...Superluminal Medicines secures $120m to fast-track GPCR drug discovery
Longevity Technology - 12-Sep-2024
Innovative platform accelerates drug discovery for metabolic diseases and more
Read more...Google DeepMind launches Alphaproteo: A game-changer in AI-driven protein design
MobiHealthNews - 10-Sep-2024
AlphaProteo redefines protein design with groundbreaking AI accuracy
Read more...Cortex Discovery unveils first AI-discovered drug to extend lifespan
Cortex Discovery - 01-Sep-2024
CortexW1 boosts lifespan of worms by 33%, highlighting AI's role in longevity research
Read more...Recursion acquired Exscientia for $688 million to form AI drug discovery platform
Longevity Technology - 09-Aug-2024
This merger aims to deliver quicker results and generate substantial revenue
Read more...Insilico Medicine showcases 10 years of AI success in drug discovery
GEN - 01-Aug-2024
AI could cut preclinical drug development time by half, but rigorous trials are crucial
Read more...Newly developed epigenetic clock 'CellPopAge' can accurately measure cellular age
Live Forever Club - 21-Jul-2024
Study also identified that compounds Torin2 and dactolisib extend Drosophila lifespan
Read more...AI speeds up search for new potential antibiotic candidates
The Guardian - 05-Jun-2024
New machine learning technique could revolutionize fight against superbugs
Read more...LabGenius raises 35 million euros to target cancer with smarter antibodies
Sifted - 21-May-2024
Leveraging robotics and machine learning to design precise cancer treatments with minimal side effects
Read more...AI-identified molecules show an impressive 80-90% success rate in Phase I trials
Live Forever Club - 20-May-2024
These early findings suggest AI could double the productivity of drug research
Read more...New AI model AlphaFold 3 predicts DNA and protein structures accurately
The Register - 09-May-2024
Though it has some flaws, it holds promise for future scientific advancements
Read more...Xaira emerges with $1 billion funding to discover life-saving drugs using AI
Longevity Technology - 24-Apr-2024
AI-powered protein design models to transform medicine with next-gen therapeutics
Read more...Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery
pharmaphorum - 08-Jan-2024
Their AlphaFold engine models proteins could lead to faster and more effective treatments
Read more...Isomorphic labs teams up with pharma giants for AI-driven drug discovery
TechCrunch - 07-Jan-2024
Eli Lilly and Novartis invest in cutting-edge AI to accelerate the search for life-saving treatments
Read more...Altos labs launches institute of computation to revolutionize medicine
Altos Labs - 09-Nov-2023
Advancing computational biology to reprogram cells and transform the future of healthcare
Read more...Alchemab unveils AntiBERTa: A machine learning model to revolutionize antibody discovery
Alchemab Therapeutics - 19-May-2022
AntiBERTa's advanced AI model unlocks deeper insights into antibody structure and function
Read more...LabGenius raises €8.9M to advance its AI and robotics-based drug discovery
Labiotech - 24-Oct-2019
Their "robot scientist" EVA is set to transform protein-based therapeutics
Read more...LabGenius gets $10M to develop protein drugs using their platform, EVA
TechCrunch - 22-Oct-2019
EVA combines machine learning, robotic automation, and synthetic biology
Read more...
